Nutex Health Q1 revenue surges 214% to $211.8M; net income $14.6M vs loss $0.4M

Nutex Health Inc.

2025-Q1 EPS reported $2.56 revenue$211,789,000

Diluted EPS $2.56 vs ($0.08) in Q1 2024; EBITDA $43.1M (+507% YoY).
Arbitration process added ~$105M in revenue, 73% of total revenue increase.
Stock-based compensation $36.1M (non-cash, one-time) weighed on GAAP net income.
Cash from operations $51.0M; cash balance $87.7M, long-term debt $21.7M.
Hospital visits up 20.5% YoY; mature hospitals revenue rose 186.5%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.